MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'breast cancer action'. Sat, 03 Sep 2011 02:39:43 +0100 http://www.medworm.com/index.php?rid=4611003&cid=t_171473_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FWXsonFvU_bM%2F Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone? And here is our regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that MTI Information Technologies, which provides marketing services to healthcare providers, hired Brian Tvenstrup as sr vp of business analytics. Previously, he headed analytics for First Equity Card, a commercial lender to small businesses, and w... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4611003 Fri, 18 Mar 2011 12:03:11 +0100 4611003 http://www.medworm.com/index.php?rid=4134258&cid=t_171473_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FAIo2G7bHgA0%2F An advocacy group known as Breast Cancer Action has been running a campaign to alert the public to a possible link between cancer and recombinant bovine growth hormone, or rBGH, which is also known as recombinant bovine somatotropin, or rbST. As part of its effort, BAC is targeting Eli Lilly, because its Elanco animal-health unit makes and sells rBST under the Posilac name, which is given to dairy cows to stimulate milk production. However, BCA has encountered some pushback. The group says that several billboard companies that do business in Indianapolis, where Lilly is headquartered, have refused to accept its ad, which reads: “Eli Lilly is making us sick. Tell them to stop.” A spokeswoman for BCA, which wants Lilly to stop making Posilac, says local and national billboard com... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4134258 Thu, 04 Nov 2010 11:34:48 +0100 4134258 http://www.medworm.com/index.php?rid=3969184&cid=t_171473_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F7rGeUjUn5rM%2F Last month, an FDA advisory committee voted 12 to 1 to recommend the agency withdraw approval for the multi-billion-dollar Avastin cancer drug to be used to treat breast cancer. The move came after two recently released studies - which were undertaken as a condition of approval - found that patients given Avastin and chemotherapy didn’t survive longer than those given chemo alone. And Avastin patients also suffered more serious side effects. Two years ago, an FDA panel voted against approval (see here), but the agency endorsed treatment for breast cancer anyway. And later this week, the FDA is expected to decide again what to do about the breast cancer indication for the drug, which is already approved to treat colon, lung and brain cancer. The impending decision is sparking heated debat... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3969184 Tue, 14 Sep 2010 13:32:32 +0100 3969184 http://www.medworm.com/index.php?rid=3592386&cid=t_171473_136_f&fid=39025&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Feverythingchangesbook%2F%7E3%2FLxoQdBpyr_s%2Fsocial-media-cancer Facebook and twitter (like a phone or radio) can be used as fluffy, brain draining diversions, or to have sophisticated conversation about issues like access to affordable care and clinical trials. So how do you use social networking to be an educated and effective cancer activist instead of a slacktivist? Seductive social media campaigns entice us to mobilize our networks to vote for projects where the most popular cause receives money and/ or exposure. (Take the Pepsi Refresh campaign – they’re so brilliant for not buying Superbowl ads this year when they can rent our brains for free on facebook instead.) The problem with these online campaigns is popularity does not equal value. The popularity of a project, a person, or organization has zero to do with their efficacy, necess... Everything Changes blogs http://www.medworm.com/rss/comments.php?id=3592386 Fri, 21 May 2010 02:55:21 +0100 3592386 http://www.medworm.com/index.php?rid=3585801&cid=t_171473_136_f&fid=39025&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Feverythingchangesbook%2F%7E3%2FLxoQdBpyr_s%2Fsocial-media-cancer Sadly, a family health issue is preventing me from attending and speaking on the Social Media Panel the OMG Summit this weekend. Urgh! So please allow me to wax about the subject here instead: Social media (like a phone or radio) can be used for fluffy, brain draining, and fun diversions. It can also be a tool to advocate for big young adult health issues like access to affordable care and clinical trials. So how do you use your social networking time wisely to become an educated and effective cancer activist instead of a slacktivist? Think about Pepsi. They’re brilliant for not to spend millions on Super Bowl ads this year because they’ve managed to rent our brains for free instead. Pepsi Refresh, and similar campaigns, award money to do-good projects receiving the most votes in the... Everything Changes blogs http://www.medworm.com/rss/comments.php?id=3585801 Fri, 21 May 2010 02:55:21 +0100 3585801 http://www.medworm.com/index.php?rid=2452341&cid=t_171473_86_f&fid=34445&url=http%3A%2F%2Fwomenshealthnews.wordpress.com%2F2009%2F06%2F04%2Fat-our-bodies-our-blog-obos-joins-aclu-lawsuit-challenging-breast-and-ovarian-cancer-gene-patents%2F On May 12, the ACLU and the Public Patent Foundation filed a lawsuit against the U.S Patent and Trademark Office, Myriad Genetics and the University of Utah Research Foundation, “charging that patents on two human genes associated with breast and ovarian cancer are unconstitutional and invalid.” The suit focuses on the BRCA1 and BRCA2 genes, mutations of which are related to increased risk of breast and/or ovarian cancers. OBOS has joined the suit as a plaintiff, along with Breast Cancer Action and others. Learn more about the suit, the issue in general, and how to sign a statement of support for the effort at Our Bodies Our Blog. Posted in Access, Rights, & Choice, Boobs, Cancer, Ethics, Laws, Legislation, & Courts, Women's Health (Source: Women's Health News) Women's Health News blogs http://www.medworm.com/rss/comments.php?id=2452341 Thu, 04 Jun 2009 13:52:10 +0100 2452341 http://www.medworm.com/index.php?rid=1854149&cid=t_171473_136_f&fid=37852&url=http%3A%2F%2Fdonnatrussell.com%2F2008%2F10%2F05%2Fteal-we-hardly-knew-ye%2F Journalist Gwen Ifill It’s October. Also known as Pink Nausea to Matthew Zachary and his merry band of upstarts at I’m Too Young for This and The Stupid Cancer Blog. Breast Cancer Action says Think Before you Pink!  But don’t think before clicking on Greetings from Cancerland columns by poet and breast-cancer survivor Alysa Cummings. Specifically In the Name of Pinkness. PINK PINK PINK PINK PINK PINK PINK What happened to teal? Ovarian? The only teal I saw in September was the Caribbean shoreline in my glossy, unsolicited, can’t-be-cancelled magazine Islands. At least we had Gwen Ifill’s knock-out jacket during the veep debate. Posted in Cancer, Poets, Writing   Tagged: alysa cummings, breast cancer, breast cancer action, breast cancer a... Donna Trussell blogs http://www.medworm.com/rss/comments.php?id=1854149 Mon, 06 Oct 2008 16:11:56 +0100 1854149 http://www.medworm.com/index.php?rid=1258588&cid=t_171473_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F241643372%2F Last week, the FDA made a surprising decision by approving Genentech’s Avastin to treat metastatic breast cancer. And the decision is seen as a possible shift in standards for assessing the effectiveness of cancer meds, because the agency granted approval based on progression-free survival - which is another way of saying the drug slowed tumor growth - rather than whether the drug extended life. The issue resonates beyond any one medication, of course, as the agency grapples with increasingly vocal cancer patients and their doctors, some of whom insist any possible benefit is worth considering. The decision may also send an important signal to drugmakers, because it can be expensive to conduct the lengthy trials needed to prove a drug can extend life. Not everyone, however, was plea... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1258588 Tue, 26 Feb 2008 18:46:42 +0100 1258588